Standout Papers

Partial residuals for the proportional hazards regression model 1982 2026 1996 2011 2.1k
  1. Partial residuals for the proportional hazards regression model (1982)
    David Schoenfeld Biometrika
  2. Driving Pressure and Survival in the Acute Respiratory Distress Syndrome (2015)
    Marcelo B. P. Amato, Maureen O. Meade et al. New England Journal of Medicine
  3. Translating the A1C Assay Into Estimated Average Glucose Values (2008)
    David M. Nathan, J.C. Kuenen et al. Diabetes Care
  4. Objective Estimates of the Probability of Death from Burn Injuries (1998)
    Colleen M. Ryan, David Schoenfeld et al. New England Journal of Medicine
  5. Sample-Size Formula for the Proportional-Hazards Regression Model (1983)
    David Schoenfeld Biometrics
  6. Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and Zalcitabine (1996)
    Ann C. Collier, Robert W. Coombs et al. New England Journal of Medicine
  7. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. (1996)
    Laurence Katznelson, Joel S. Finkelstein et al. The Journal of Clinical Endocrinology & Metabolism
  8. Pulmonary-Artery versus Central Venous Catheter to Guide Treatment of Acute Lung Injury (2006)
    Arthur P. Wheeler, Gordon R. Bernard et al. New England Journal of Medicine
  9. Clozapine, Diabetes Mellitus, Weight Gain, and Lipid Abnormalities: A Five-Year Naturalistic Study (2000)
    David C. Henderson, Enrico Cagliero et al. American Journal of Psychiatry
  10. Pamidronate to Prevent Bone Loss during Androgen-Deprivation Therapy for Prostate Cancer (2001)
    Matthew R. Smith, Francis J. McGovern et al. New England Journal of Medicine
  11. Changes in Body Composition during Androgen Deprivation Therapy for Prostate Cancer (2002)
    Matthew R. Smith, Joel S. Finkelstein et al. The Journal of Clinical Endocrinology & Metabolism
  12. Comparison of the Sp o 2 /F io 2 Ratio and the Pa o 2 /F io 2 Ratio in Patients With Acute Lung Injury or ARDS (2007)
    Todd W. Rice, Arthur P. Wheeler et al. CHEST Journal
  13. An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study (2013)
    Timothy M. Miller, Alan Pestronk et al. The Lancet Neurology
  14. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint radiation therapy oncology group and eastern cooperative oncology group study (1983)
    Chu H. Chang, John Horton et al. Cancer
  15. Epidemiology of mutations in superoxide dismutase in amyotrophic lateal sclerosis (1997)
    Merit Cudkowicz, D. McKenna‐Yasek et al. Annals of Neurology

Immediate Impact

5 from Science/Nature 70 standout
Sub-graph 1 of 22

Citing Papers

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
2020 Standout
1 intermediate paper

Works of David Schoenfeld being referenced

Nonlinear Imputation of Pao 2/Fio 2 From Spo 2/Fio 2 Among Mechanically Ventilated Patients in the ICU: A Prospective, Observational Study
2017
Nonlinear Imputation of Pao2/Fio2 From Spo2/Fio2 Among Patients With Acute Respiratory Distress Syndrome
2016
and 1 more

Author Peers

Author Last Decade Papers Cites
David Schoenfeld 1991 4602 3130 5750 4812 342 32.3k
Aeilko H. Zwinderman 626 5801 1898 7159 3273 654 40.3k
Samy Suissa 1226 3773 1362 9397 4286 483 32.5k
Liam Smeeth 933 7667 1249 4466 3884 617 38.6k
Christopher H. Schmid 1321 8041 1162 7122 6591 392 60.9k
Frits R. Rosendaal 183 3137 1102 3536 2657 803 40.2k
Jesse A. Berlin 1495 4385 1209 3444 3824 286 38.0k
James F. Fries 273 4543 1760 4888 896 246 59.1k
Stephen Burgess 1097 6938 1256 2500 4444 327 44.7k
Alan J. Silman 211 3789 681 2158 3479 420 44.9k
Giuseppe Lippi 572 7657 4612 4916 3197 1.6k 50.5k

All Works

Loading papers...

Rankless by CCL
2026